224 related articles for article (PubMed ID: 23459571)
1. Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Olsson T; Achiron A; Alfredsson L; Berger T; Brassat D; Chan A; Comi G; Eraksoy M; Hegen H; Hillert J; Jensen PE; Moiola L; Myhr KM; Oturai A; Schippling S; Siva A; Sorensen PS; Trampe AK; Weber T; Potts J; Plavina T; Paes D; Subramanyam M; Wiendl H; Dib H; Uren D; Hemmer B; Buck D
Mult Scler; 2013 Oct; 19(11):1533-8. PubMed ID: 23459571
[TBL] [Abstract][Full Text] [Related]
2. Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Trampe AK; Hemmelmann C; Stroet A; Haghikia A; Hellwig K; Wiendl H; Goelz S; Ziegler A; Gold R; Chan A
Neurology; 2012 May; 78(22):1736-42. PubMed ID: 22592369
[TBL] [Abstract][Full Text] [Related]
3. Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1.
Bozic C; Richman S; Plavina T; Natarajan A; Scanlon JV; Subramanyam M; Sandrock A; Bloomgren G
Ann Neurol; 2011 Nov; 70(5):742-50. PubMed ID: 22162056
[TBL] [Abstract][Full Text] [Related]
4. Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial.
Bozic C; Subramanyam M; Richman S; Plavina T; Zhang A; Ticho B
Eur J Neurol; 2014 Feb; 21(2):299-304. PubMed ID: 24894998
[TBL] [Abstract][Full Text] [Related]
5. Anti-JC-virus antibody prevalence in a German MS cohort.
Warnke C; Dehmel T; Posevitz-Fejfár A; Chan A; Berthele A; Schmidt S; Haas J; Kronsbein HC; Seitz F; Tackenberg B; Mäurer M; Gerbershagen K; Limmroth V; Adams O; Hartung HP; Gold R; Hemmer B; Wiendl H; Kieseier BC
Mult Scler; 2012 Jul; 18(7):1054-5. PubMed ID: 22740609
[No Abstract] [Full Text] [Related]
6. Anti-JC virus antibody sera positivity and index value among patients with multiple sclerosis may be correlated with age, sex, and area of residence.
Koolaji S; Allahabadi NS; Ahmadi A; Eskandarieh S; Moghadasi AN; Azimi AR; Sahraian MA
J Neurovirol; 2018 Oct; 24(5):570-576. PubMed ID: 29785581
[TBL] [Abstract][Full Text] [Related]
7. JCV epidemiology in MS (JEMS)--epidemiology of anti-JCV antibody prevalence in multiple sclerosis patients--Portuguese data.
da Silva AM; Santos ME;
J Neurol Sci; 2014 Feb; 337(1-2):119-22. PubMed ID: 24369270
[TBL] [Abstract][Full Text] [Related]
8. The effect of plasma exchange on serum anti-JC virus antibodies.
Subramanyam M; Plavina T; Khatri BO; Fox RJ; Goelz SE
Mult Scler; 2013 Jun; 19(7):912-9. PubMed ID: 23232602
[TBL] [Abstract][Full Text] [Related]
9. Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
Bloomgren G; Richman S; Hotermans C; Subramanyam M; Goelz S; Natarajan A; Lee S; Plavina T; Scanlon JV; Sandrock A; Bozic C
N Engl J Med; 2012 May; 366(20):1870-80. PubMed ID: 22591293
[TBL] [Abstract][Full Text] [Related]
10. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
[TBL] [Abstract][Full Text] [Related]
11. Anti-JC virus antibody titres increase over time with natalizumab treatment.
Raffel J; Gafson AR; Malik O; Nicholas R
Mult Scler; 2015 Dec; 21(14):1833-8. PubMed ID: 26449743
[TBL] [Abstract][Full Text] [Related]
12. Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis.
Branco LP; Adoni T; Apostolos-Pereira SL; Brooks JBB; Correa EC; Damasceno CA; Eboni ACB; Fezer L; Gama PDD; Goncalves MVM; Gomes S; Grzesiuk AK; Mendes MF; Morales RR; Muniz A; Parolin MFK; Pimentel MLV; Ribeiro MC; Santos GACD; Sato HK; Scherpenhuijzen SB; Scorcine C; Siquineli F; Sousa NAC; Varela DL; Winckler TCA; Fragoso YD
Arq Neuropsiquiatr; 2018 Sep; 76(9):588-591. PubMed ID: 30365621
[TBL] [Abstract][Full Text] [Related]
13. JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
Outteryck O; Zéphir H; Salleron J; Ongagna JC; Etxeberria A; Collongues N; Lacour A; Fleury MC; Blanc F; Giroux M; de Seze J; Vermersch P
Mult Scler; 2014 Jun; 20(7):822-9. PubMed ID: 24072722
[TBL] [Abstract][Full Text] [Related]
14. Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort.
Dominguez-Mozo MI; Rus M; Santiago JL; Izquierdo G; Casanova I; Galan V; Garcia-Martinez MA; Arias-Leal AM; García-Montojo M; Pérez-Pérez S; Arroyo R; Alvarez-Lafuente R
Eur J Clin Invest; 2017 Feb; 47(2):158-166. PubMed ID: 28036121
[TBL] [Abstract][Full Text] [Related]
15. Anti-JC virus seroprevalence in a Finnish MS cohort.
Kolasa M; Hagman S; Verkkoniemi-Ahola A; Airas L; Koivisto K; Elovaara I
Acta Neurol Scand; 2016 May; 133(5):391-7. PubMed ID: 26347001
[TBL] [Abstract][Full Text] [Related]
16. Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of Spanish Multiple Sclerosis patients treated with natalizumab.
Dominguez-Mozo MI; Garcia-Montojo M; De Las Heras V; Garcia-Martinez A; Arias-Leal AM; Casanova I; Arroyo R; Alvarez-Lafuente R
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1277-86. PubMed ID: 23979860
[TBL] [Abstract][Full Text] [Related]
17. Correlation between anti-JC-virus and anti-cytomegalovirus, -Epstein-Barr virus and -measles/-rubella/-varicella-zoster-virus antibodies.
Auer M; Borena W; Holm-von Laer D; Deisenhammer F
J Med Virol; 2017 Jan; 89(1):3-9. PubMed ID: 27253624
[TBL] [Abstract][Full Text] [Related]
18. JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severity.
Huppke P; Hummel H; Ellenberger D; Pfeifenbring S; Stark W; Huppke B; Brück W; Gärtner J
Mult Scler; 2015 Apr; 21(4):382-7. PubMed ID: 25070674
[TBL] [Abstract][Full Text] [Related]
19. Anti-JC Virus Antibody Prevalence in Canadian MS Patients.
Bhan V; Lapierre Y; Freedman MS; Duquette P; Selchen D; Migounov V; Walt L; Zhang A
Can J Neurol Sci; 2014 Nov; 41(6):748-52. PubMed ID: 25377521
[TBL] [Abstract][Full Text] [Related]
20. Natalizumab therapy is associated with changes in serum JC virus antibody indices over time.
Peters J; Williamson E
J Neurol; 2017 Dec; 264(12):2409-2412. PubMed ID: 29034436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
